Metformin has reliably been lowering blood sugar levels for diabetics for over half a century. However, new research suggests the drug may also be combating additional conditions, including cancer and heart disease. For more than 60 years, millions have turned to metformin to help manage their diabetes and the complications that come with it. But despite its widespread use, the exact ways metformin works have remained a mystery – until now. Recent research shows how metformin actually functions and the beneficial effects the drug brings, providing insight into the wonder drugs’ broader therapeutic potential.
The Role of Mitochondria in Metformin’s Action
A study conducted by Northwestern Medicine has brought forward crucial evidence on how metformin works on a cellular level. The study revealed that metformin actually hijacks a cell’s energy production process by targeting mitochondria, the powerhouse of the cell. More specifically, the drug stops mitochondrial complex I, a key enzyme in the cellular energy-making machinery, from doing its thing. In doing so, metformin reduces the glucose production of a cell and, in turn, lowers blood sugar levels, which is a big deal when trying to manage diabetes. These findings have given researchers a clearer picture into of metformin’s mechanisms.
How Metformin Works on Mitochondrial Complex I
Metformin’s ability to lower blood glucose is directly linked with its relationship to mitochondrial complex I. When this complex is unable to function, the energy production in the cell is disrupted, leading to glucose production losses. The most interesting part is that this process happens selectively and only in certain cell types; more specifically, the liver, kidney, and gut, which is where metformin is most effective. The authors suggest that the selective nature could be specific targeting of cells that are contributing to the disease’s progression without affecting any of the healthy cells.
Animal Studies and Experimental Evidence
Te better explore this phenomenon, the researchers bred genetically modified mice with a yeast enzyme (NDI1) that mimics mitochondrial complex I, but remained unaffected by metformin. With the glucose-lowering effects being significantly reduced, the study supported that mitochondrial complex I does indeed play a role in how the drug works. It is worth noting that the mice were not fully resistant to metformin’s effects, meaning there may be other contributors to the drug’s effectiveness.
Read More: In World First, Stem Cell Therapy Reverses Type 1 Diabetes in Patient
A Broad Spectrum of Effects
While metformin is primarily known for managing Type 2 diabetes, the drug’s capabilities extend far beyond glucose control. Studies suggest it may have anti-cancer, inflammation reduction, and even anti-COVID-19 properties. These effects may also be linked to the drug’s action on mitochondria, which has opened up another whole discussion of the importance of the mitochondria. For example, previous research by the Chandel group showed that metformin could slow cancer cell growth by also targeting mitochondrial complex I.
Metformin’s History
Metformin’s journey as a medicinal compound actually dates back centuries. Originally taken from a French lilac plant, it was used in the 1700s to treat “sweet urine disease,” (today’s diabetes). The active ingredient in the plant was isolated and, thanks to modern medicine, refined into the drug we now use. Metformin has had widespread use since the 1950s, and has been officially approved to combat diabetes in Europe since 1958. Despite its long history, the full extent of the drug’s capabilities has only recently been explored.
Even More Potential
Studies have further suggested that metformin could even help prevent or at least treat conditions like heart disease and cognitive decline. One of the driving factors in these hypotheses is that metformin activates AMPK, an enzyme that helps regulate cellular metabolism and protects cells from stress. AMPK activation could in theory protect cells across various tissues, including the cardiovascular system, offering benefits beyond managing diabetes.
Current Research and Future Directions
Unfortunately, most research is limited because it is a generic drug. Large pharmaceutical companies don’t show much interest in funding trials that have nothing to do with diabetes. But there is one study still going on – funded by the Department of Veterans Affairs – exploring metformin’s ability to reduce the risk of prediabetic heart attacks, strokes, or other cardiovascular events. This study may provide the evidence needed to confirm metformin’s role as a broader protective drug, opening doors for additional clinical trails.
The Road Ahead for Metformin
The now “wonder drug‘s” notoriety is likely to grow as research continues. Recent findings regarding mitochondrial complex I already support a detailed understanding of how metformin lowers blood glucose, which probably already explains some of its broader effects. Further research is definitely still needed to fully realize the drug’s potential, but the future does look promising for diabetics and non-diabetics alike. As more evidence emerges, metformin may prove to be a cornerstone for a multitude of prescriptions, not just diabetes.
Read More: 9 Early Signs of Diabetes You May Not Be Noticing